您当前的位置：
首页 >
文章列表页 >
The effects of evolocumab combined with atorvastatin on post-PCI efficacy and coronary microcirculation in patients with acute ST-segment elevation myocardial infarction
更新时间：2025-12-10

    • The effects of evolocumab combined with atorvastatin on post-PCI efficacy and coronary microcirculation in patients with acute ST-segment elevation myocardial infarction

    • “In the field of cardiovascular disease treatment, experts from the First Affiliated Hospital of Nanyang Medical College have found through comparative research that the combination of Elomumab and Atorvastatin treatment can more effectively reduce postoperative blood lipid levels, improve inflammation status, endothelial function, and coronary microcirculation in patients with acute STEMI after PCI, and the safety is comparable.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 23, Pages: 2958-2962(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.23.13    

      CLC： R972+.6;R969.4

    • Received：15 July 2025，

      Revised：2025-10-17，

      Accepted：04 November 2025，

      Published：15 December 2025

    移动端阅览

  • ZHU Yun,HAN Keli,LI Jie,et al.The effects of evolocumab combined with atorvastatin on post-PCI efficacy and coronary microcirculation in patients with acute ST-segment elevation myocardial infarction[J].ZHONGGUO YAOFANG,2025,36(23):2958-2962. DOI： 10.6039/j.issn.1001-0408.2025.23.13.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Meta-analysis of efficacy and safety of intranasal corticosteroids combined with oral H1-antihistamine in the treatment of allergic rhinitis
Clinical observation of Shouhui tongbian capsule combined with linaclotide in the treatment of constipation-predominant irritable bowel syndrome
Efficacy and safety comparison of dupilumab versus thalidomide in the treatment of refractory prurigo nodularis in adults
Advances in the clinical application and safety of bispecific antibodies for cancer therapy
Efficacy and safety of ruxolitinib in the treatment of myelofibrosis

Related Author

CHEN Huajiao
LUO Xiaohua
XIONG Qiong
YANG Liu
HAO Manxia
WANG Shengwen
YAO Lishan
ZHANG Jianbo

Related Institution

Dept. of Otorhinolaryngology-Head and Neck Surgery， Chongqing University Fuling Hospital
Dept. of Traditional Chinese Medicine， Nanyang First People’s Hospital
Dept. of Proctology， Nanyang First People’s Hospital
Dept. of Traditional Chinese Medicine Pharmacy， Nanyang Central Hospital
Dept. of Pharmacy， Wuhan First Hospital
0